Eco-villains: when activism turns into sabotage

Vittoria Brambilla and Sara Zenoni have launched the first Italian field trials, respectively with gene-edited rice and grapevine, both targeted by antibiotech vandals

Do you remember the activists who threw tomato puree on art masterpieces? Of course we do. News reports, collective outrage, and calls for exemplary punishment followed. To stop such actions in Italy, Law Number 6 of January 22, 2024, was passed, introducing Sanctioning provisions on the destruction, dispersion, deterioration, defacement, and illegal use of cultural or landscape heritage.” Now for another question: Do you remember the activists who tore down protective nets, uprooted plants born from Italian research, and sabotaged experiments designed to make agriculture more sustainable? Probably not — because they acted at night with their faces covered. And because both the media and politicians had little to say when these incidents happened — in June 2024 against the University of Milan and in February 2025 against the University of Verona.

Continue reading

The rare story of Sonia and Eric: pioneers by force and by love

A scientific adventure whose ingredients include the looming threat of a fatal disease, the decision to reinvent themselves as biologists, and the goal of silencing prions.

The clinical trial with antisense oligonucleotides, born of their efforts, is considered one of the most interesting trials of 2025, but this is only a part of the story. This married couple is also pursuing other avenues to halt the onset of prion diseases. In the summer of 2024, they published a study in Science using epigenetic editing in mice. Then, in January 2025, their experiments with base editing were published in Nature Medicine. Yet Sonia Vallabh was a newly graduated jurist, and her husband, Eric Minikel, was working in urban planning, when they discovered that she carried a mutation that would condemn her to die of fatal familial insomnia within two or three decades.

Continue reading

The Economist explores the age of CRISPR

At first glance, it looks like the cover of a design magazine, but it’s actually the technology supplement published by The Economist in March. Titled ‘The Age of CRISPR,’ it features eight articles exploring the most cutting-edge areas of genome editing—gene therapies, xenotransplantation, epigenetic editing, gene drives, gene-edited plants, and much more. It doesn’t shy away from the challenges, from companies struggling to stay afloat to regulatory hurdles. But the tone is measured: the era of sensationalism is over, yet CRISPR is here to stay.

Continue reading

Agricultural Sciences: Yesterday, Today, and Tomorrow

Charles Valentine Memorial Lecture, 20 Nov. 2024 (C.S. Prakash, Lisa Ainsworth, Anastasia Bodnar, and Kate Tully)

I want to highlight a lecture recently given by one of the most influential scientists in the international debate on GMOs and gene editing in agriculture. Born in India, C. S. Prakash lives and works in the U.S. and has been elected a fellow of the American Association for the Advancement of Science (AAAS). His lecture, delivered at the AAAS Center for Scientific Evidence in Public Issues, traces the progress made over the past sixty years in the field of global food security—i.e., meeting the growing demand for food from the world’s population.

Continue reading

The Huge Little Thing: NanoCas is Coming

3D structure of the NanoCas system [Mammoth Biosciences]

It is currently only a preprint on bioRxiv, but it has already attracted significant attention from the scientific community and the journal Science. Mammoth Biosciences, a company founded by CRISPR co-inventor Jennifer Doudna, has developed NanoCas, a mini-editor that is just one-third the size of traditional gene-editing scissors (Cas9).

Continue reading

Eco-vandals target gene-edited Chardonnay in Italy

On the night of February 12-13, unknown vandals broke into a small experimental vineyard at the University of Verona in northern Italy to uproot Chardonnay vines that had been gene-edited to resist a fungal infection. Last September, the launch of this field trial was celebrated by researchers, producers, and prominent politicians—including Agriculture Minister Francesco Lollobrigida—because it was a point of pride for the country (the first field with gene-edited vines in Europe) and a step toward healthier, more sustainable viticulture, less reliant on fungicides. Anti-science belligerence strikes again: two experimental fields have been launched in Italy, and both have been attacked.

Continue reading

A Cambrian explosion for CAR-T

Credit Mesa Shumacher/Santa Fe Institute

Around 500 million years ago, life on Earth underwent a phase of rapid diversification that led to the formation of complex biological structures and the appearance of new groups of organisms. This crucial event for evolution captured the imagination so strongly that it became a metaphor. ‘CARs in 2025: the Cambrian explosion continues’, in fact, is the title chosen by Michel Sadelain for the lecture hosted by GEN (Genetic Engineering & Biotechnology News) on 29 January. The most exciting branch of immunotherapy, using engineered T lymphocytes to efficiently and selectively attack cancer cells, is experiencing a boom in new approaches and applications.

Continue reading

Record living with a pig kidney: 60 days and counting

Dr. Jayme Locke, Towana Looney, and Dr. Robert Montgomery
 Credit: Mateo Salcedo/NYU Langone Health

The other xenograft patients arrived at the operating theatre in critical condition, which likely contributed to why none of them survived beyond two months. Towana Looney, however, was in better health when she received the pig kidney edited to reduce the risk of rejection. She benefited from the insights gained from earlier attempts and, on January 25, celebrated a record sixty days with an animal organ. She is the first patient to receive a kidney from a pig with 10 genetic modifications and is currently the only person in the world living with a pig organ.

A for Avocado, B for Banana, C for CRISPR Cannabis

As 2025 starts, where does CRISPR stand in transforming agriculture? The Innovative Genomics Institute has provided a snapshot of the state of the art, and (despite the wait for new European regulations), things are moving forward. Let’s take a closer look.

Continue reading